CNA Explains: Nipah virus - what you need to know

Key Concepts

• Nepa Virus (Nipah Virus): A zoonotic virus transmitted from animals to humans, primarily via fruit bats and pigs, and through human-to-human contact.
• Zoonotic Virus: A virus that can be transmitted from animals to humans.
• Encephalitis: Inflammation of the brain, a severe complication of Nipah virus infection.
• Pneumonia: Inflammation of the lungs, another severe complication of Nipah virus infection.
• Outbreak Control: Measures taken to contain the spread of a disease, including contact tracing, screening, and surveillance.

Regional Outbreak and Initial Response

Since December, India has confirmed two cases of the Nipah virus in West Bengal. Both confirmed patients are healthcare workers, indicating potential for further transmission within the medical system. A crucial aspect of the response has been the tracing and testing of nearly 200 close contacts, all of whom have tested negative to date. This outbreak has prompted regional action, with Thailand initiating screening of passengers arriving from West Bengal at major airports. Cambodia and Nepal have also begun checking travelers originating from India, and Jakarta has increased supervision of all international arrivals. This proactive approach highlights the concern surrounding the virus’s potential for international spread.

Understanding the Nipah Virus

The Nipah virus is a zoonotic virus, meaning it originates in animals and then transmits to humans. The primary reservoirs are fruit bats and pigs. Transmission to humans occurs through direct contact with infected animals, consumption of contaminated food (particularly date palm sap contaminated by bat saliva), or close contact with an infected person. The virus was first identified in humans in 1998 during an outbreak in Malaysia and Singapore. This initial outbreak centered around pig farms in Malaysia, resulting in approximately 180 human infections.

Symptoms and Severity

The incubation period for the Nipah virus is typically within two weeks. Initial symptoms are often non-specific and can mimic influenza, including fever, headache, muscle pain, vomiting, and sore throat. However, the virus can progress to more severe complications. In severe cases, Nipah virus attacks the lungs, leading to pneumonia, or the brain, causing encephalitis – inflammation of the brain. Encephalitis is the primary driver of the virus’s high mortality rate, which can reach up to 75% of infected individuals.

Treatment and Prevention

Currently, there is no approved vaccine or specific antiviral drug to treat Nipah virus infection. Treatment focuses on supportive care, managing symptoms, and preventing secondary infections. A health expert noted that the virus is “not as transmissible as COVID-19,” offering a degree of reassurance, but emphasizing the need for vigilance. As of the time of reporting, there are no confirmed cases of Nipah virus outside of India. However, given the extensive travel links throughout Asia, preventative measures are being prioritized. The report explicitly states that “prevention is the only real defense” against the Nipah virus.

Logical Connections & Data

The report establishes a clear connection between the initial outbreak in India and the subsequent preventative measures taken by neighboring countries. The data point of “up to three out of four people” dying from the infection underscores the severity of the virus and justifies the rapid response. The historical context of the 1998 outbreak in Malaysia and Singapore provides a precedent for the potential scale of the current situation. The report logically progresses from identifying the outbreak to explaining the virus itself, its symptoms, and the current limitations in treatment, culminating in the emphasis on preventative measures.